PBMs
Pharmacy Benefit Managers (PBM) are third-party administrators of prescription drug programs for health plans. They are under increasing government scrutiny. This health industry sector that has seen significant consolidation and some PBMs now have larger revenue than big drug manufacturers. Their role in the price and availability of certain medications has attracted the attention of both the House and the Senate, and here STAT covers the latest issues on pharmacy benefit management.
Latest
STAT Plus: White House is told the big three PBMs are ‘everything wrong with this industry’
STAT Plus: White House to hold a listening session on reforming pharmacy benefit managers
STAT Plus: FTC says pharmacy benefit managers are stonewalling requests for information
STAT Plus: Congress punts on PBM reform efforts
STAT Plus: FTC to probe the role of middlemen in worsening drug shortage crisis
STAT Plus: A year in, the U.S. is still not taking advantage of lower-cost biosimilars for Humira
STAT Plus: House panel passes key PBM reform for sliver of commercial market
All Coverage
advertisement
